Insomnia Treatment Market
- 2026 年市場規模
- USD 4.4 Bn
- 2033 年預估規模
- USD 5.93 Bn
- 年複合成長率 CAGR
- 4.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Insomnia Treatment Market, By Treatment Type (Drug and Device), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels), By Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America)
報告摘要
Insomnia, or sleeplessness, is a sleep disorder in which people have trouble sleeping. Signs and symptoms may include difficulty falling or staying asleep and not feeling well-rested. Sleeping pills may also be used, but should be monitored for side effects. Sometimes prescription drugs used to treat depression may ease insomnia when taken in lower doses. Cognitive behavioral therapy for insomnia, CBT-I, is usually recommended as the first line of treatment. CBT-I is a structured program that helps people identify and replace thoughts and behaviors that cause or worsen sleep problems with habits that promote sound sleep.
Market Dynamics
High prevalence of sleep disorders, growing demand for safe and effective treatment, increase in awareness among people, and rapidly growing geriatric population worldwide is expected to augment the growth of the global insomnia treatment market during the forecast period. The prevalence of insomnia is higher in elderly than in the younger population. Physiologic changes of aging, chronic medical illnesses, and environmental conditions contribute to insomnia in the elderly. Thus, with the growing geriatric population, the demand for safe & effective insomnia treatment worldwide. For instance, according to the World Health Organization (WHO), one in six people in the world will be aged 60 years or over by 2030, and the world’s population of people aged 60 years and older will double (2.1 billion) by 2050.
Key features of the study
• This report provides in-depth analysis of the global insomnia treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global insomnia treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Innovative Neurological Devices, Cerêve Inc., Sanofi SA, Pfizer Inc., Paratek Pharmaceuticals Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Ltd., Ebb Therapeutics, and Electromedical Products International Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global insomnia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insomnia treatment market.
Market Segmentation
• Treatment Type Insights (Revenue, USD Bn, 2026 - 2033)
o Drug
o Device
• Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Other Distribution Channels
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players Insights
o Innovative Neurological Devices
o Cerêve Inc.
o Sanofi SA
o Pfizer Inc.
o Paratek Pharmaceuticals Inc.
o Merck & Co. Inc.
o Takeda Pharmaceutical Company Ltd.
o Ebb Therapeutics
o Electromedical Products InternatAional Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Global Insomnia Treatment Market, By Treatment Type
Global Insomnia Treatment Market, By Distribution Channel
Global Insomnia Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trend
4. Global Insomnia Treatment Market, By Treatment Type, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Device
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
5. Global Insomnia Treatment Market, By Distribution Channel, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Other Distribution Channels
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
6. Global Insomnia Treatment Market, By Region, 2020 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Innovative Neurological Devices
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Cerêve Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Paratek Pharmaceuticals Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck & Co. Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Takeda Pharmaceutical Company Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Ebb Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Electromedical Products International Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
9. References and Research Methodology
o References
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們